QS Investors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,301
Closed -$2.18M 1737
2020
Q1
$2.18M Sell
12,301
-600
-5% -$113K 0.03% 394
2019
Q4
$2.48M Sell
12,901
-852
-6% -$154K 0.02% 518
2019
Q3
$2.31M Sell
13,753
-6,581
-32% -$1.07M 0.03% 520
2019
Q2
$3.4M Hold
20,334
0.04% 397
2019
Q1
$2.98M Sell
20,334
-18
-0.1% -$2.61K 0.03% 441
2018
Q4
$2.72M Buy
20,352
+7,076
+53% +$1.16M 0.04% 407
2018
Q3
$2.53M Sell
13,276
-1,200
-8% -$220K 0.02% 544
2018
Q2
$2.41M Buy
14,476
+10
+0.1% +$1.6K 0.02% 553
2018
Q1
$2.43M Hold
14,466
0.03% 512
2017
Q4
$2.37M Sell
14,466
-687
-5% -$123K 0.02% 551
2017
Q3
$3.11M Sell
15,153
-17,673
-54% -$4.11M 0.03% 463
2017
Q2
$7.98M Sell
32,826
-1,816
-5% -$427K 0.07% 176
2017
Q1
$8.28M Sell
34,642
-2,283
-6% -$532K 0.07% 171
2016
Q4
$7.75M Sell
36,925
-410
-1% -$84.9K 0.06% 214
2016
Q3
$8.6M Sell
37,335
-2,336
-6% -$571K 0.07% 232
2016
Q2
$9.17M Sell
39,671
-885
-2% -$204K 0.08% 222
2016
Q1
$10.9M Sell
40,556
-161
-0.4% -$46.1K 0.1% 188
2015
Q4
$12.7M Sell
40,717
-283
-0.7% -$84.3K 0.12% 151
2015
Q3
$11.1M Buy
41,000
+15,618
+62% +$4.8M 0.12% 166
2015
Q2
$7.7M Buy
25,382
+7,175
+39% +$2.14M 0.1% 265
2015
Q1
$5.42M Buy
18,207
+13,714
+305% +$3.91M 0.06% 350
2014
Q4
$1.16M Sell
4,493
-2,100
-32% -$525K 0.01% 696
2014
Q3
$1.59M Buy
6,593
+718
+12% +$161K 0.04% 274
2014
Q2
$1.31M Buy
5,875
+2,690
+84% +$557K 0.04% 336
2014
Q1
$655K Sell
3,185
-25,532
-89% -$5.06M 0.02% 419
2013
Q4
$4.83M Buy
28,717
+22,732
+380% +$3.55M 0.18% 118
2013
Q3
$861K Sell
5,985
-34,115
-85% -$4.54M 0.04% 357
2013
Q2
$5.07M Buy
+40,100
New +$4.54M 0.18% 164

Other funds holding AGN

QS Investors's AGN Position: Q2 2020 in Review

QS Investors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,301 shares — an estimated $2.18M sold.

QS Investors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $12.7M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • QS Investors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • QS Investors sold 12,301 Allergan plc shares in Q2 2020, an estimated $2.18M.
  • QS Investors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • QS Investors's Allergan plc position peaked at $12.7M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on QS Investors's 13F filing for Q2 2020, filed 14 Aug 2020.